Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Sarah L. Kerns PhD

Sarah L. Kerns PhD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Teaching

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0002-6503-0011

Member of the Cancer Center


I am willing to mentor a junior faculty member.
I am willing to collaborate on research projects.


Publications (68)

  • Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study. (Heumann P, Aguado-Barrera ME, Avuzzi B, Azria D, Briers E, Bultijnck R, Choudhury A, De Ruysscher D, Farcy-Jacquet MP, Fonteyne V, Gómez Caamaño A, Helmbold I, Johnson K, Kerns SL, Lambrecht M, Lingard Z, Rancati T, Rosenstein BS, Sperk E, Paul Symonds R, Talbot C, Valdagni R, Vega A, Veldeman L, Ward T, Webb A, West CM, Chang-Claude J, Seibold P, REQUITE Consortium) Radiother Oncol 2022 Nov 25;178:109426 PMID: 36442608 SCOPUS ID: 2-s2.0-85145571653 11/29/2022    
  • Prevention of Radiation-Induced Bladder Injury: A Murine Study Using Captopril. (Groves AM, Paris N, Hernady E, Johnston CJ, Aljitawi O, Lee YF, Kerns SL, Marples B) Int J Radiat Oncol Biol Phys 2022 Nov 16 PMID: 36400304 SCOPUS ID: 2-s2.0-85144350267 11/19/2022    
  • The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study. (van der Weijst L, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Giandini T, Giraldo A, Gutiérrez-Enríquez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Lambrecht M, Lang P, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Valladares B, Talbot CJ, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, Lievens Y, REQUITE consortium) Radiother Oncol 2022 Nov;176:127-137 PMID: 36195214 SCOPUS ID: 2-s2.0-85139824384 10/05/2022    
  • Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort. (Webb AJ, Harper E, Rattay T, Aguado-Barrera ME, Azria D, Bourgier C, Brengues M, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Cicchetti A, De Ruysscher D, De Santis MC, Dunning AM, Elliott RM, Fachal L, Gómez-Caamaño A, Gutiérrez-Enríquez S, Johnson K, Lobato-Busto R, Kerns SL, Post G, Rancati T, Reyes V, Rosenstein BS, Seibold P, Seoane A, Sosa-Fajardo P, Sperk E, Taboada-Valladares B, Valdagni R, Vega A, Veldeman L, Ward T, West CM, Symonds RP, Talbot CJ, REQUITE Consortium) EBioMedicine 2022 Oct;84:104269 PMID: 36130474 PMCID: PMC9486558 SCOPUS ID: 2-s2.0-85138088248 09/22/2022    
  • No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity. (Barnett GC, Kerns SL, Dorling L, Fachal L, Aguado-Barrera ME, Martínez-Calvo L, Jandu HK, Welsh C, Tyrer J, Coles CE, Haviland JS, Parker C, Gómez-Caamaño A, Calvo-Crespo P, Sosa-Fajardo P, Burnet NG, Summersgill H, Webb A, De Ruysscher D, Seibold P, Chang-Claude J, Talbot CJ, Rattay T, Parliament M, De Ruyck K, Rosenstein BS, Pharoah PDP, Dunning AM, Vega A, West CML, RGC and REQUITE Consortia) Int J Radiat Oncol Biol Phys 2022 Nov 01;114(3):494-501 PMID: 35840111 SCOPUS ID: 2-s2.0-85138029152 07/16/2022       2 Citations
  • Exploratory Analysis of Associations Between Whole Blood Mitochondrial Gene Expression and Cancer-Related Fatigue Among Breast Cancer Survivors. (Kleckner AS, Kleckner IR, Culakova E, Wojtovich AP, Klinedinst NJ, Kerns SL, Hardy SJ, Inglis JE, Padula GDA, Mustian KM, Janelsins MC, Dorsey SG, Saligan LN, Peppone LJ) Nurs Res 2022 Sep-Oct 01;71(5):411-417 PMID: 35416182 PMCID: PMC9420746 SCOPUS ID: 2-s2.0-85137124750 04/14/2022       1 Citation
  • A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis (Schack LMH, Naderi E, Fachal L, Dorling L, Luccarini C, Dunning AM, Barnett G, Barrera MEA, Burnet NG, Calvo LM, Diergaarde B, Dudding T, Dunning A, Duprez F, Kerns SL, Kiang MCL, Langendijk H, Mehanna H, Ness A, Sim AYL, Spiessens A, Summersgill HR, Tajes JF, Vega A, Welsh C, Wen EOH, West C, Ong EHW, Chua MLK, Langendijk JA, Alizadeh BZ, Overgaard J, Eriksen JG, Andreassen CN, Alsner J) British Journal of Cancer 1 April 2022;126(7):1082-1090 SCOPUS ID: 2-s2.0-85122900536 04/01/2022       2 Citations
  • Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). (Van der Weijst L, Aguado-Barrera ME, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Calvo-Crespo P, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Dunning AM, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Gutiérrez-Enríquez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Mollà M, Lambrecht M, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa-Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Lorenzo B, Talbot CJ, Valdagni R, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, REQUITE Consortium, Lievens Y) Lung Cancer 2022 Apr;166:228-241 PMID: 35334417 PMCID: PMC9698940 SCOPUS ID: 2-s2.0-85126700189 03/26/2022       1 Citation
  • Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. (Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Symonds RP, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, REQUITE Consortium) Radiother Oncol 2022 Mar;168:75-82 PMID: 35077710 PMCID: PMC8986577 SCOPUS ID: 2-s2.0-85123912429 01/26/2022       2 Citations
  • Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer. (Janelsins MC, Lei L, Netherby-Winslow C, Kleckner AS, Kerns S, Gilmore N, Belcher E, Thompson BD, Werner ZA, Hopkins JO, Long J, Cole S, Culakova E) J Neuroimmunol 2022 Jan 15;362:577769 PMID: 34871864 SCOPUS ID: 2-s2.0-85120439514 12/07/2021       1 Citation
  • Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity. (Franco NR, Massi MC, Ieva F, Manzoni A, Paganoni AM, Zunino P, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Veldwijk MR, Herskind C, Avuzzi B, Noris Chiorda B, Valdagni R, Azria D, Farcy-Jacquet MP, Brengues M, Rosenstein BS, Stock RG, Vega A, Aguado-Barrera ME, Sosa-Fajardo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T, REQUITE Consortium Collaborators) Radiother Oncol 2021 Jun;159:241-248 PMID: 33838170 PMCID: PMC8754257 SCOPUS ID: 2-s2.0-85104332700 04/11/2021       4 Citations
  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. (Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Muir K, Lophatananon A, Wan P, Le Marchand L, Wilkens LR, Stevens VL, Gapstur SM, Carter BD, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Giles GG, Southey MC, MacInnis RJ, Cybulski C, Wokołorczyk D, Lubiński J, Neal DE, Donovan JL, Hamdy FC, Martin RM, Nordestgaard BG, Nielsen SF, Weischer M, Bojesen SE, Røder MA, Iversen P, Batra J, Chambers S, Moya L, Horvath L, Clements JA, Tilley W, Risbridger GP, Gronberg H, Aly M, Szulkin R, Eklund M, Nordström T, Pashayan N, Dunning AM, Ghoussaini M, Travis RC, Key TJ, Riboli E, Park JY, Sellers TA, Lin HY, Albanes D, Weinstein SJ, Mucci LA, Giovannucci E, Lindstrom S, Kraft P, Hunter DJ, Penney KL, Turman C, Tangen CM, Goodman PJ, Thompson IM Jr, Hamilton RJ, Fleshner NE, Finelli A, Parent MÉ, Stanford JL, Ostrander EA, Geybels MS, Koutros S, Freeman LEB, Stampfer M, Wolk A, Håkansson N, Andriole GL, Hoover RN, Machiela MJ, Sørensen KD, Borre M, Blot WJ, Zheng W, Yeboah ED, Mensah JE, Lu YJ, Zhang HW, Feng N, Mao X, Wu Y, Zhao SC, Sun Z, Thibodeau SN, McDonnell SK, Schaid DJ, West CML, Burnet N, Barnett G, Maier C, Schnoeller T, Luedeke M, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Koudou YA, John EM, Grindedal EM, Maehle L, Khaw KT, Ingles SA, Stern MC, Vega A, Gómez-Caamaño A, Fachal L, Rosenstein BS, Kerns SL, Ostrer H, Teixeira MR, Paulo P, Brandão A, Watya S, Lubwama A, Bensen JT, Fontham ETH, Mohler J, Taylor JA, Kogevinas M, Llorca J, Castaño-Vinyals G, Cannon-Albright L, Teerlink CC, Huff CD, Strom SS, Multigner L, Blanchet P, Brureau L, Kaneva R, Slavov C, Mitev V, Leach RJ, Weaver B, Brenner H, Cuk K, Holleczek B, Saum KU, Klein EA, Hsing AW, Kittles RA, Murphy AB, Logothetis CJ, Kim J, Neuhausen SL, Steele L, Ding YC, Isaacs WB, Nemesure B, Hennis AJM, Carpten J, Pandha H, Michael A, De Ruyck K, De Meerleer G, Ost P, Xu J, Razack A, Lim J, Teo SH, Newcomb LF, Lin DW, Fowke JH, Neslund-Dudas C, Rybicki BA, Gamulin M, Lessel D, Kulis T, Usmani N, Singhal S, Parliament M, Claessens F, Joniau S, Van den Broeck T, Gago-Dominguez M, Castelao JE, Martinez ME, Larkin S, Townsend PA, Aukim-Hastie C, Bush WS, Aldrich MC, Crawford DC, Srivastava S, Cullen JC, Petrovics G, Casey G, Roobol MJ, Jenster G, van Schaik RHN, Hu JJ, Sanderson M, Varma R, McKean-Cowdin R, Torres M, Mancuso N, Berndt SI, Van Den Eeden SK, Easton DF, Chanock SJ, Cook MB, Wiklund F, Nakagawa H, Witte JS, Eeles RA, Kote-Jarai Z, Haiman CA) Nat Genet 2021 Jan;53(1):65-75 PMID: 33398198 PMCID: PMC8148035 SCOPUS ID: 2-s2.0-85098923871 01/06/2021       111 Citations
  • A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. (Massi MC, Gasperoni F, Ieva F, Paganoni AM, Zunino P, Manzoni A, Franco NR, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Symonds PR, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Avuzzi B, Giandini T, Valdagni R, Cicchetti A, Azria D, Jacquet MF, Rosenstein BS, Stock RG, Collado K, Vega A, Aguado-Barrera ME, Calvo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T) Front Oncol 2020;10:541281 PMID: 33178576 PMCID: PMC7593843 SCOPUS ID: 2-s2.0-85094590165 11/13/2020       9 Citations
  • Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. (Collado K, Kerns SL, Diefenbach MA, Peterson-Roth E, Koski R, Ostrer H, Stock RG, Mattessich M, Kaplan P, Rosenstein BS) Adv Radiat Oncol 2020;5(5):897-904 PMID: 33083651 PMCID: PMC7557145 SCOPUS ID: 2-s2.0-85085332668 10/22/2020    
  • Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors. (Kerns SL, Fung C, Fossa SD, Dinh PC Jr, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB) JNCI Cancer Spectr 2020 Aug;4(4):pkaa022 PMID: 32704617 PMCID: PMC7368467 07/25/2020    
  • Oncology Scan: Radiation Biology and Genomic Predictors of Response. (Marples B, Kerns S) Int J Radiat Oncol Biol Phys 2020 Jul 01;107(3):393-397 PMID: 32531379 PMCID: PMC8725062 SCOPUS ID: 2-s2.0-85086102222 06/13/2020    
  • Genomics models in radiotherapy: From mechanistic to machine learning. (Kang J, Coates JT, Strawderman RL, Rosenstein BS, Kerns SL) Med Phys 2020 Jun;47(5):e203-e217 PMID: 32418335 PMCID: PMC8725063 SCOPUS ID: 2-s2.0-85084787632 05/18/2020       8 Citations
  • Relationship of cisplatin-related adverse health outcomes with disability and unemployment among testicular cancer survivors (Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB) JNCI Cancer Spectrum 2020;4(4) SCOPUS ID: 2-s2.0-85101332203 01/01/2020       8 Citations
  • The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists. (Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, Sawakuchi GO, Shaitelman SF, Powell SN, Woodward WA) Int J Radiat Oncol Biol Phys 2019 Nov 15;105(4):698-712 PMID: 31381960 SCOPUS ID: 2-s2.0-85073559407 08/06/2019       51 Citations
  • Multicenter Randomized Controlled Trial of Omega-3 Fatty Acids Versus Omega-6 Fatty Acids for the Control of Cancer-Related Fatigue Among Breast Cancer Survivors. (Peppone LJ, Inglis JE, Mustian KM, Heckler CE, Padula GDA, Mohile SG, Kamen CS, Culakova E, Lin PJ, Kerns SL, Cole S, Janelsins MC) JNCI Cancer Spectr 2019 Jun;3(2):pkz005 PMID: 31119206 PMCID: PMC6512349 SCOPUS ID: 2-s2.0-85073528138 05/24/2019       12 Citations
  • Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. (Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, Burnet NG, Dearnaley DP, Gulliford SL, Hall E, Sydes MR, Aguado-Barrera ME, Gómez-Caamaño A, Carballo AM, Peleteiro P, Lobato-Busto R, Stock R, Stone NN, Ostrer H, Usmani N, Singhal S, Tsuji H, Imai T, Saito S, Eeles R, DeRuyck K, Parliament M, Dunning AM, Vega A, Rosenstein BS, West CML) J Natl Cancer Inst 2020 Feb 01;112(2):179-190 PMID: 31095341 PMCID: PMC7019089 SCOPUS ID: 2-s2.0-85073569172 05/17/2019       50 Citations
  • Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. (Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J, Young K, Lei L, Bautista J, Mohamed M, Mohile SG, Ambrosone CB, Liu S, Janelsins MC) Clin Epigenetics 2019 Mar 12;11(1):45 PMID: 30867049 PMCID: PMC6416954 SCOPUS ID: 2-s2.0-85062824329 03/15/2019       25 Citations
  • Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. (Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ) Nutr Cancer 2019;71(1):21-40 PMID: 30688088 PMCID: PMC6456409 SCOPUS ID: 2-s2.0-85064045281 01/29/2019       38 Citations
  • Germline variation at 8q24 and prostate cancer risk in men of European ancestry. (Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ, PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA) Nat Commun 2018 Nov 05;9(1):4616 PMID: 30397198 PMCID: PMC6218483 SCOPUS ID: 2-s2.0-85056250910 11/07/2018       29 Citations
  • Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. (Morton LM, Kerns SL, Dolan ME) Am Soc Clin Oncol Educ Book 2018 May 23;38(38):775-786 PMID: 30231410 PMCID: PMC6415750 09/21/2018    
  • Machine Learning and Radiogenomics: Lessons Learned and Future Directions. (Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, Schwartz R, Kim S, Rosenstein BS) Front Oncol 2018;8:228 PMID: 29977864 PMCID: PMC6021505 SCOPUS ID: 2-s2.0-85048976391 07/07/2018       37 Citations
  • Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. (Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman P, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger G, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West C, Dunning AM, Burnet N, Mucci L, Giovannucci E, Andriole G, Cussenot O, Cancel-Tassin G, Koutros S, Freeman LEB, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein B, Kerns S, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Fachal L, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weisher M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Slavov C, Mitev V, Parliament M, Singhal S, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Kierzek A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Kraft P, PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Freedman M, Wiklund F, Chanock S, Henderson BE, Easton DF, Haiman CA, Eeles RA, Conti DV, Kote-Jarai Z) Nat Commun 2018 Jun 11;9(1):2256 PMID: 29892050 PMCID: PMC5995836 SCOPUS ID: 2-s2.0-85048420948 06/13/2018       62 Citations
  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. (Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA, Profile Study, Australian Prostate Cancer BioResource (APCB), IMPACT Study, Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Cancer of the Prostate in Sweden (CAPS), Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium) Nat Genet 2018 Jul;50(7):928-936 PMID: 29892016 PMCID: PMC6568012 SCOPUS ID: 2-s2.0-85048333838 06/13/2018       379 Citations
  • Radiation biology and oncology in the genomic era. (Kerns SL, Chuang KH, Hall W, Werner Z, Chen Y, Ostrer H, West C, Rosenstein B) Br J Radiol 2018 Nov;91(1091):20170949 PMID: 29888979 PMCID: PMC6475928 SCOPUS ID: 2-s2.0-85053833312 06/12/2018       17 Citations
  • Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study. (Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB, Platinum Study Group) J Clin Oncol 2018 May 20;36(15):1505-1512 PMID: 29617189 PMCID: PMC5959198 SCOPUS ID: 2-s2.0-85047195082 04/05/2018       52 Citations
  • Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. (Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH) Int J Radiat Oncol Biol Phys 2018 May 01;101(1):128-135 PMID: 29502932 PMCID: PMC5886789 SCOPUS ID: 2-s2.0-85042565518 03/06/2018       43 Citations
  • Preconditioned random forest regression: Application to genome-wide study for radiotherapy toxicity prediction (Lee S, Ostrer H, Kerns S, Deasy JO, Rosenstein B, Oh JH) ACM-BCB 2017 - Proceedings of the 8th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics 20 August 2017:593 SCOPUS ID: 2-s2.0-85031322640 08/20/2017    
  • Radiogenomics and radiotherapy response modeling. (El Naqa I, Kerns SL, Coates J, Luo Y, Speers C, West CML, Rosenstein BS, Ten Haken RK) Phys Med Biol 2017 Aug 01;62(16):R179-R206 PMID: 28657906 PMCID: PMC5557376 SCOPUS ID: 2-s2.0-85026832006 06/29/2017       36 Citations
  • Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. (Azria D, Lapierre A, Gourgou S, De Ruysscher D, Colinge J, Lambin P, Brengues M, Ward T, Bentzen SM, Thierens H, Rancati T, Talbot CJ, Vega A, Kerns SL, Andreassen CN, Chang-Claude J, West CML, Gill CM, Rosenstein BS) Front Oncol 2017;7:83 PMID: 28497027 PMCID: PMC5406456 SCOPUS ID: 2-s2.0-85019032512 05/13/2017       28 Citations
  • Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. (Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group) J Clin Oncol 2017 Apr 10;35(11):1211-1222 PMID: 28240972 PMCID: PMC5455601 SCOPUS ID: 2-s2.0-85017304402 02/28/2017       61 Citations
  • Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes. (Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO) Sci Rep 2017 Feb 24;7:43381 PMID: 28233873 PMCID: PMC5324069 SCOPUS ID: 2-s2.0-85013851581 02/25/2017       23 Citations
  • Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement. (De Ruysscher D, Defraene G, Ramaekers BLT, Lambin P, Briers E, Stobart H, Ward T, Bentzen SM, Van Staa T, Azria D, Rosenstein B, Kerns S, West C) Radiother Oncol 2016 Dec;121(3):440-446 PMID: 27979370 PMCID: PMC5557371 SCOPUS ID: 2-s2.0-85006399698 12/17/2016       14 Citations
  • Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? (Herskind C, Talbot CJ, Kerns SL, Veldwijk MR, Rosenstein BS, West CM) Cancer Lett 2016 Nov 01;382(1):95-109 PMID: 26944314 PMCID: PMC5016239 SCOPUS ID: 2-s2.0-84960185958 10/22/2016       57 Citations
  • Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. (Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, Stock R, Stone NN, Sydes MR, Tyrer JP, Ahmed S, Parliament M, Ostrer H, Rosenstein BS, Vega A, Burnet NG, Dunning AM, Barnett GC, West CM, Radiogenomics Consortium) EBioMedicine 2016 Aug;10:150-63 PMID: 27515689 PMCID: PMC5036513 SCOPUS ID: 2-s2.0-85027953807 08/16/2016       56 Citations
  • Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. (Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J, International Radiogenomics Consortium (RgC)) Radiother Oncol 2016 Dec;121(3):431-439 PMID: 27443449 PMCID: PMC5559879 SCOPUS ID: 2-s2.0-84997428777 07/23/2016       80 Citations
  • Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. (Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB) J Clin Oncol 2016 Aug 10;34(23):2712-20 PMID: 27354478 PMCID: PMC5019759 SCOPUS ID: 2-s2.0-84981272252 06/30/2016       143 Citations
  • Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. (Ahmed M, Dorling L, Kerns S, Fachal L, Elliott R, Partliament M, Rosenstein BS, Vega A, Gómez-Caamaño A, Barnett G, Dearnaley DP, Hall E, Sydes M, Burnet N, Pharoah PD, Eeles R, West CM) Br J Cancer 2016 May 10;114(10):1165-74 PMID: 27070714 PMCID: PMC4865979 SCOPUS ID: 2-s2.0-84963621704 04/14/2016       15 Citations
  • TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis. (Baijer J, Déchamps N, Perdry H, Morales P, Kerns S, Vasilescu A, Baulande S, Azria D, Roméo PH, Schmitz A) Oncotarget 2016 Apr 19;7(16):21416-27 PMID: 26982083 PMCID: PMC5008295 SCOPUS ID: 2-s2.0-84965010117 03/17/2016       12 Citations
  • The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changes. (Knoll MA, Salvatore M, Sheu RD, Knoll AD, Kerns SL, Lo YC, Rosenzweig KE) Quant Imaging Med Surg 2016 Feb;6(1):35-41 PMID: 26981453 PMCID: PMC4775239 SCOPUS ID: 2-s2.0-84994758745 03/17/2016       10 Citations
  • How Will Big Data Improve Clinical and Basic Research in Radiation Therapy? (Rosenstein BS, Capala J, Efstathiou JA, Hammerbacher J, Kerns SL, Kong FS, Ostrer H, Prior FW, Vikram B, Wong J, Xiao Y) Int J Radiat Oncol Biol Phys 2016 Jul 01;95(3):895-904 PMID: 26797542 PMCID: PMC4864183 SCOPUS ID: 2-s2.0-84969940603 01/23/2016       22 Citations
  • Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial. (Bourgier C, Kerns S, Gourgou S, Lemanski C, Gutowski M, Fenoglietto P, Romieu G, Crompton N, Lacombe J, Pèlegrin A, Ozsahin M, Rosenstein B, Azria D) Ann Oncol 2016 Mar;27(3):474-80 PMID: 26681684 PMCID: PMC4907345 SCOPUS ID: 2-s2.0-84959905660 12/19/2015       27 Citations
  • Lhermitte's Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism. (Ko HC, Powers AR, Sheu RD, Kerns SL, Rosenstein BS, Krieger SC, Mourad WF, Hu KS, Gupta V, Bakst RL) PLoS One 2015;10(10):e0139448 PMID: 26448647 PMCID: PMC4598033 SCOPUS ID: 2-s2.0-84948661476 10/09/2015       5 Citations
  • The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. (Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS) Semin Radiat Oncol 2015 Oct;25(4):281-91 PMID: 26384276 PMCID: PMC4576690 SCOPUS ID: 2-s2.0-84941554669 09/19/2015       41 Citations
  • Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. (Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG) Clin Oncol (R Coll Radiol) 2015 Oct;27(10):579-87 PMID: 26166774 SCOPUS ID: 2-s2.0-84941315223 07/15/2015       33 Citations
  • XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. (Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, Koch CA, Dunning AM, Burnet N, Bliss JM, Symonds RP, Rattay T, Suga T, Kerns SL, Bourgier C, Vallis KA, Sautter-Bihl ML, Claßen J, Debus J, Schnabel T, Rosenstein BS, Wenz F, West CM, Popanda O, Chang-Claude J) Int J Radiat Oncol Biol Phys 2015 Aug 01;92(5):1084-1092 PMID: 26072091 SCOPUS ID: 2-s2.0-84937516788 06/15/2015       58 Citations
  • Radiogenomics: the search for genetic predictors of radiotherapy response. (Kerns SL, West CM, Andreassen CN, Barnett GC, Bentzen SM, Burnet NG, Dekker A, De Ruysscher D, Dunning A, Parliament M, Talbot C, Vega A, Rosenstein BS) Future Oncol 2014 Dec;10(15):2391-406 PMID: 25525847 SCOPUS ID: 2-s2.0-84920023936 12/20/2014       58 Citations
  • A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes. (Kerns SL, Guevara-Aguirre J, Andrew S, Geng J, Guevara C, Guevara-Aguirre M, Guo M, Oddoux C, Shen Y, Zurita A, Rosenfeld RG, Ostrer H, Hwa V, Dauber A) J Clin Endocrinol Metab 2014 Oct;99(10):E2117-22 PMID: 25057881 PMCID: PMC4184067 SCOPUS ID: 2-s2.0-84907662133 07/25/2014       38 Citations
  • A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. (Fachal L, Gómez-Caamaño A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL, Sánchez-García M, Lobato-Busto R, Dorling L, Elliott RM, Dearnaley DP, Sydes MR, Hall E, Burnet NG, Carracedo Á, Rosenstein BS, West CM, Dunning AM, Vega A) Nat Genet 2014 Aug;46(8):891-4 PMID: 24974847 SCOPUS ID: 2-s2.0-84905580203 07/01/2014       102 Citations
  • Radiogenomics: radiobiology enters the era of big data and team science. (Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, Drumea K, Dunning AM, Easton D, Eeles R, Fachal L, Gutiérrez-Enríquez S, Haustermans K, Henríquez-Hernández LA, Imai T, Jones GD, Kerns SL, Liao Z, Onel K, Ostrer H, Parliament M, Pharoah PD, Rebbeck TR, Talbot CJ, Thierens H, Vega A, Witte JS, Wong P, Zenhausern F, Radiogenomics Consortium) Int J Radiat Oncol Biol Phys 2014 Jul 15;89(4):709-13 PMID: 24969789 PMCID: PMC5119272 SCOPUS ID: 2-s2.0-84903188157 06/28/2014       78 Citations
  • A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. (Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE, Dearnaley DP, Rosenstein BS, Vega A, Symonds P, Yarnold J, Baynes C, Michailidou K, Dennis J, Tyrer JP, Wilkinson JS, Gómez-Caamaño A, Tanteles GA, Platte R, Mayes R, Conroy D, Maranian M, Luccarini C, Gulliford SL, Sydes MR, Hall E, Haviland J, Misra V, Titley J, Bentzen SM, Pharoah PD, Burnet NG, Dunning AM, West CM) Radiother Oncol 2014 May;111(2):178-85 PMID: 24785509 SCOPUS ID: 2-s2.0-84902545584 05/03/2014       111 Citations
  • Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. (Kerns SL, Ostrer H, Rosenstein BS) Cancer Discov 2014 Feb;4(2):155-65 PMID: 24441285 PMCID: PMC3946319 SCOPUS ID: 2-s2.0-84893439855 01/21/2014       81 Citations
  • Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268. (Cespedes MS, Kerns SL, Holzman RS, McLaren PJ, Ostrer H, Aberg JA) HIV Clin Trials 2013;14(6):292-302 PMID: 24334182 PMCID: PMC4118741 SCOPUS ID: 2-s2.0-84890521035 12/18/2013       1 Citation
  • STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics. (Kerns SL, de Ruysscher D, Andreassen CN, Azria D, Barnett GC, Chang-Claude J, Davidson S, Deasy JO, Dunning AM, Ostrer H, Rosenstein BS, West CM, Bentzen SM) Radiother Oncol 2014 Jan;110(1):182-8 PMID: 23993398 PMCID: PMC4786020 SCOPUS ID: 2-s2.0-84896080866 09/03/2013       56 Citations
  • Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics. (De Ruysscher D, Sharifi H, Defraene G, Kerns SL, Christiaens M, De Ruyck K, Peeters S, Vansteenkiste J, Jeraj R, Van Den Heuvel F, van Elmpt W) Acta Oncol 2013 Oct;52(7):1405-10 PMID: 23957564 SCOPUS ID: 2-s2.0-84884545769 08/21/2013       43 Citations
  • Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. (Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, Hixson R, Rosenstein BS, Ostrer H) Radiother Oncol 2013 Jun;107(3):372-6 PMID: 23719583 PMCID: PMC3787843 SCOPUS ID: 2-s2.0-84881475896 05/31/2013       68 Citations
  • A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. (Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS) J Urol 2013 Jul;190(1):102-8 PMID: 23376709 SCOPUS ID: 2-s2.0-84878825562 02/05/2013       49 Citations
  • Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. (Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J, Coles CE, Gutiérrez-Enríquez S, Fuentes-Raspall MJ, Alonso-Muñoz MC, Kerns S, Raabe A, Symonds RP, Seibold P, Talbot CJ, Wenz F, Wilkinson J, Yarnold J, Dunning AM, Rosenstein BS, West CM, Bentzen SM) Radiother Oncol 2012 Dec;105(3):289-95 PMID: 23199655 PMCID: PMC3593101 SCOPUS ID: 2-s2.0-84871182048 12/04/2012       56 Citations
  • Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma. (Buckstein M, Kerns S, Forysthe K, Stone NN, Stock RG) BJU Int 2013 Mar;111(3 Pt B):E43-7 PMID: 23046084 SCOPUS ID: 2-s2.0-84874707797 10/11/2012       8 Citations
  • A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. (Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS) Int J Radiat Oncol Biol Phys 2013 Jan 01;85(1):e21-8 PMID: 23021708 PMCID: PMC3616619 SCOPUS ID: 2-s2.0-84871377389 10/02/2012       52 Citations
  • Geminin is required for zygotic gene expression at the Xenopus mid-blastula transition. (Kerns SL, Schultz KM, Barry KA, Thorne TM, McGarry TJ) PLoS One 2012;7(5):e38009 PMID: 22662261 PMCID: PMC3360639 SCOPUS ID: 2-s2.0-84861471202 06/05/2012       14 Citations
  • Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship. (Guevara-Aguirre J, Guevara-Aguirre M, Hwa V, Prócel P, Saavedra J, Ostrer H, Fang P, Rosenfeld RG, Kerns S, Rosenbloom AL) Eur J Endocrinol 2012 Mar;166(3):521-9 PMID: 22170795 SCOPUS ID: 2-s2.0-84857941135 12/16/2011       10 Citations
  • Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. (Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1292-300 PMID: 20932654 PMCID: PMC2991431 SCOPUS ID: 2-s2.0-78549233654 10/12/2010       123 Citations
  • Geminin prevents rereplication during xenopus development. (Kerns SL, Torke SJ, Benjamin JM, McGarry TJ) J Biol Chem 2007 Feb 23;282(8):5514-21 PMID: 17179155 SCOPUS ID: 2-s2.0-34247171325 12/21/2006       28 Citations
  • Last update: 01/23/2023